Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats

Psychoneuroendocrinology

Volumn 32, Issue 7, 2007, Pages 777-784

  Murashita, Mari ^a   Kusumi, Ichiro ^a   Hosoda, Hiroshi ^b   Kangawa, Kenji ^b   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenergic receptor; Clozapine; Diabetes mellitus; Ghrelin; Neurotransmitter; Obesity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLOZAPINE; DOPAMINE; GHRELIN; GLUCOSE; HISTAMINE; INSULIN; LEPTIN; MUSCARINE; NEUROTRANSMITTER; PRAZOSIN; SEROTONIN; YOHIMBINE;

ANIMAL EXPERIMENT; APPETITE DISORDER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MECHANISM; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; WEIGHT GAIN;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN; LEPTIN; MALE; PEPTIDE HORMONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTRANSMITTER;

EID: 34547546693     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.05.007     Document Type: Article

References (41)

1. Allison D.B., Montore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., and Weiden P.J. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 156 (1999) 1686-1696
2. American Diabetes Association, American Psychiatry Association, American Association of Clinical Endocrinologists and North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27 (2004) 596-601
3. Ardizzone T.D., Bradley R.J., Freeman III A.M., and Dwyer D.S. Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine. Brain Res. 923 (2001) 82-90
4. Ariyasu H., Tanaka K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., and Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86 (2001) 4753-4758
5. Bromel T., Blum W.F., Ziegler A., Schulz E., Bender M., Fleischhaker C., Remschmidt H., Krieg J.C., and Hebebrand J. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol. Psychiatry 3 (1998) 76-80
6. 1b-adrenergic receptor subtype. J. Biol. Chem. 279 (2004) 1108-1115
7. Chaouloff F., Laude D., and Baudrie D.V. Effects of the 5-HT1C/2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat. Eur. J. Pharmacol. 177 (1990) 107-110
8. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.S., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
9. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., and Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346 (2002) 1623-1630
10. Date Y., Murakami N., Toshinai K., Matsukura S., Nijima A., Matsuo H., Kangawa K., and Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 (2002) 1120-1128
11. Dunning B.E., and Taborsky G.J. Neural control of islet function by norepinephrine and sympathetic neuropeptides. Adv. Exp. Med. Biol. 291 (1991) 107-127
12. Dwyer D.S., Pinkofsky H.B., Liu Y., and Bradley R.J. Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 23 (1999) 69-80
13. Dwyer D.S., and Donohoe D. Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol. Biochem. Behav. 75 (2003) 255-260
14. Elman I., Goldstein D.S., Eisenhofer G., Foklio J., Malhotra A.K., Adler C.M., Pickar D., and Breier A. Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacology 20 (1999) 29-43
15. Flechtner-Mors M., Jenkinson C.P., Alt A., Biesalski H.K., Adler G., and Ditschuneit H.H. Sympathetic regulation of glucose uptake by the α-adrenoreceptor in human obesity. Obesity Res. 12 (2004) 612-620
16. Haring C., Meise U., and Humpel C. Dose related plasma levels of clozapine: influence of smoking behavior, sex and age. Psychopharmacology 99 (1989) S38-S40
17. Henderson D.C., Cagliero E., Gray C., Nasrallah R.A., Hayden D.L., Schoenfeld D.A., and Goff D.C. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am. J. Psychiatry 157 (2000) 975-981
18. Hosoda H., and Kangawa K. Ghrelin regulation of autonomic nerve system. Folia Endocrinol. Japonia 81 (2005) P192 (Abstract)
19. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279 (2000) 909-913
20. Hosoda H., Doi K., Nagaya N., Okimura H., Nakagawa E., Enomoto M., Ono F., and Kangawa K. Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin. Chem. 50 (2004) 1077-1080
21. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
22. Krediet R.T., and Dunning A.J. Baroreflex sensitivity in hypertension during beta-adrenergic blockade. Br. Heart J. 41 (1979) 106-110
23. Lean M.E.J., and Pajonk F.G. Patients on atypical antipsychotic drugs. Diabetes Care 26 (2003) 1596-1597
24. Mark A.L., Rahmouni K., Correia M., and Haynes W.G. A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat. Acta. Physiol. Scand. 177 (2003) 345-349
25. Meltzer H.Y. Monitoring clozapine. Hosp. Community Psychiatry 41 (1990) 1356-1357
26. Meltzer H.Y., Matsubara S., and Lee J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonine 2 pKi values. J. Pharmacol. Exp. Ther. 251 (1989) 238-246
27. Murashita M., Kusumi I., Inoue T., Takahashi Y., Hosoda H., Kangawa K., and Koyama T. Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30 (2005) 106-110
28. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
29. Newcomer J.W., Haupt D.W., Fucetola R., Melson A.K., Schweiger J.A., Cooper B.P., and Selke G. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 59 (2002) 337-345
30. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124 (1996) 57-73
31. Schwartz M.W., Woods S.C., Porte Jr. D., Seeley R.J., and Bakin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
32. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., and Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 (2001) 227-232
33. Sivitz W.I., Fink B.D., Morgan D.A., Fox J.M., Donohue P.A., and Haynes W.G. Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats. Am. J. Physiol. 277 (1999) E668-E677
34. Spivak B., Roitman S., Vered Y., Master R., Graff E., Talmon Y., Guy N., Gonen N., and Weizman A. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin. Neuropharmacol. 21 (1998) 245-250
35. Sugimoto Y., and Yamada J. Effects of 5-HT2A receptor antagonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats. Biol. Pharm. Bull. 23 (2000) 1521-1523
36. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., and Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 (1995) 542-546
37. Wirshing D.A., Wirshing W.C., Kysar L., Berisford M.A., Goldstein D., Pashdag J., Mintz J., and Marder S.R. Novel antipsychotics: comparison of weight gain liabilities. J. Clin. Psychiatry 60 (1999) 358-363
38. Wren A.M., Small C.J., and Ward H.L. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
39. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Choen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., and Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547
40. Yamaguchi N. Sympathoadrenal system in neuroendocrine control of glucose : mechanism involved in the liver, pancreas, and adrenal gland under hemorrhagic and hypoglycemia stress. Can. J. Physiol. Pharmacol. 70 (1992) 167-206
41. Young C.R., Bowers M.B., and Mazure C.M. Management of adverse effects of clozapine. Schizophr. Bull. 24 (1988) 381-390